Lv1
20 积分 2022-04-21 加入
The Yin and Yang of regulatory T cell and therapy progress in autoimmune disease
3个月前
已完结
Drug targets in the cytokine universe for autoimmune disease
3个月前
已完结
Bone marrow hematopoiesis drives multiple sclerosis progression
4个月前
已完结
Efficacy and safety of upadacitinib for 16‐week extended induction and 52‐week maintenance therapy in patients with moderately to severely active ulcerative colitis
4个月前
已完结
Selective tyrosine kinase 2 inhibitors in inflammatory bowel disease
4个月前
已完结
Janus Kinase Inhibitors Differentially Inhibit Specific Cytokine Signals in the Mesenteric Lymph Node Cells of Inflammatory Bowel Disease Patients
10个月前
已完结
Discovery of a Potent and Selective Tyrosine Kinase 2 Inhibitor: TAK-279
11个月前
已完结
Biomarker Changes during 20 Years Preceding Alzheimer’s Disease
1年前
已完结
Current paradigms of pathogenesis and challenges in vitiligo translational research
1年前
已关闭
Innate lymphoid cells and innate-like T cells in cancer — at the crossroads of innate and adaptive immunity
1年前
已完结
皖公网安备34019202002308
